Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Expanded Access Data Supported Lutathera Approval, US FDA Notes

Jan 29 2018

• By Michael Cipriano

Related Content

Keeping Track: Shutdown Edition

Jan 29 2018

Reagan-Udall Expanded Access Navigator Ready To Launch

May 12 2017

Right-To-Try Legislation Must Change Language To Narrow Spectrum Of Patients, Gottlieb Says

Oct 04 2017

Expanded Access: FDA To Clarify How Adverse Events Impact Drug Approval Process

Jul 21 2017

Related Companies

Advanced Accelerator Applications SA

Novartis AG

Sarepta Therapeutics, Inc.

Additional Topics

United States Drug Approval Standards Legislation Approvals Regulation Cancer BioPharmaceutical

More from Approval Standards

More from Pathways & Standards

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.